Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30(+) Lymphoma

Brentuximab vedotin is an antibody-conjugated chemotherapy targeting CD30 indicated in treatment of several lymphomas. We report the first 3 cases of cytomegalovirus severe infections with retinitis following this treatment. Evolution was favorable, but relapse occurred after treatment rechallenge....

Descripción completa

Detalles Bibliográficos
Autores principales: Tudesq, Jean-Jacques, Vincent, Laure, Lebrun, Julie, Hicheri, Yosr, Gabellier, Ludovic, Busetto, Timothé, Merle, Corinne, Fegueux, Nathalie, Ceballos, Patrice, Quittet, Philippe, Navarro, Robert, Hillaire-Buys, Dominique, Cartron, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473439/
https://www.ncbi.nlm.nih.gov/pubmed/28638848
http://dx.doi.org/10.1093/ofid/ofx091

Ejemplares similares

Ejemplares similares